Earlier this year, we asked 21 Dorwest customers to take part in a trial for our new cognitive supplement, BrainCopa®, all with dogs needing different levels of cognitive support. The trial included a variety of breeds with ages from 7 to 15 years. At the 28 day trial period, we asked the participants to complete a survey and here are the results…

• 67% of dogs trialled saw an increase in responsiveness to the environment, including interacting directly with the environment through interest in scents or playing with toys.
  
• Over 71% noted an increase in general energy levels.
  
• 79% of participants seeing a decrease in restless behaviours at quiet times, including overnight, a key symptom of most cognitive issues in dogs.
  
• 56% also saw decreased confusion and disorientation, with 52% noting decreased anxiety levels.
  
• 90% of all participants noted that the tablets were extremely palatable for their dog, with three owners crushing the tablets for easy administration with food.

Improvements were seen by 43% of participants within 3 weeks of starting the tablets at the recommended daily dose and within the recommended 4 weeks 90% of participants saw improvements.

Comments from the trial included: